Your pipeline number is the most-quoted and least-trusted figure in your business. "We have $2M in pipeline" gets said in every board meeting and believed by no one who has watched a quarter close, because the number conflates deals that will close, deals that might, and deals that died months ago but nobody has had the courage to mark dead. A sales pipeline diagnostic is the practice of reading past that headline number to the pipeline's actual vital signs — its coverage, its velocity, its aging, its stage-by-stage conversion, and its slippage — so you can tell the difference between a healthy engine and a graveyard with a big total at the bottom. This guide is the diagnostic: the specific signals to measure, what an abnormal reading on each one means, and how to turn the read into a fix.
The reason a diagnostic beats the headline number is that the total hides the structure. Two companies can both report $2M in pipeline; one has it spread across fresh, fast-moving, well-qualified deals and the other has it concentrated in a handful of ancient deals that have slipped four times. The totals are identical; the realities could not be more different. Only a diagnostic that decomposes the pipeline into its vital signs can tell you which company you are — and almost every founder who runs one for the first time discovers they are closer to the graveyard than they thought.
The Five Vital Signs
A pipeline diagnostic reads five signals. Each tells you something the headline total cannot, and read together they reveal whether your pipeline is an asset or an illusion.
- Coverage. The ratio of pipeline value to the quota you need to close. Healthy is usually 3–4× for a normal close rate; far below means you cannot mathematically hit the number, far above can mean inflated junk.
- Velocity. How fast value moves through the pipeline — a function of deal count, win rate, deal size, and cycle length. Velocity, not the static total, is what actually predicts revenue.
- Aging. How long deals have sat in their current stage. Anything older than ~1.5× your average cycle is probably dead weight inflating your total.
- Stage conversion. The percentage advancing from each stage to the next. The steepest drop-off is your structural bottleneck.
- Slippage. How often deals push their close date. Chronic slippage is the clearest sign a forecast is fiction and qualification is weak.
Coverage: Can You Mathematically Hit the Number?
Coverage is the first read because it answers a yes/no question: given your real win rate, is there enough qualified pipeline to hit quota at all? If you need to close $500K this quarter and you historically win 25% of qualified pipeline, you need roughly $2M of genuine pipeline — a 4× coverage ratio. Most teams quote a coverage number built on their total pipeline rather than their qualified pipeline, which is how a company with "3× coverage" still misses badly: two-thirds of that coverage was never real. The diagnostic forces you to compute coverage against scrubbed, qualified pipeline, which usually reveals the real ratio is far thinner than the headline suggested.
Velocity: The Metric That Actually Predicts Revenue
A static pipeline total is a snapshot; velocity is the motion, and motion is what becomes revenue. Pipeline velocity combines four levers — the number of qualified opportunities, the win rate, the average deal size, and the length of the sales cycle — into a single measure of how much value the engine produces over time. The formula is straightforward: multiply opportunities, win rate, and deal size, then divide by cycle length. Its real value is diagnostic: it shows you which lever to pull. A company can lift velocity by improving any of the four, and the diagnostic reveals which one is the cheapest, fastest win — often shortening the cycle or raising win rate rather than chasing more opportunities.
Velocity also reframes a debate founders waste months on: whether to "get more leads" or "hire more reps." Both are attempts to raise revenue by adding opportunity count, the single most expensive lever of the four. The diagnostic frequently shows that a modest improvement in win rate or a shorter cycle produces the same revenue lift at a fraction of the cost — and unlike buying leads, those gains compound on every future deal rather than evaporating when the spend stops.
Coverage, velocity, aging, slippage — a real diagnostic reads them together. The 47-Point Sales Audit is the exact internal checklist we run on B2B pipelines. Download it and get a complete read in five minutes.
Get the 47-Point Audit →Aging: Finding the Dead Weight
Every pipeline accumulates zombies — deals that should have closed or died long ago but linger because no one will declare them dead. The aging read finds them. Sort every open deal by how long it has sat in its current stage and flag everything older than roughly 1.5 times your average sales cycle. These deals are almost always dead; they survive only because marking them lost feels like admitting failure, and because a bigger pipeline total feels reassuring. The diagnostic's job is to strip this dead weight out, because a pipeline full of zombies does three harmful things at once: it inflates coverage into a false sense of safety, it corrupts your conversion math, and it wastes rep attention on deals that will never close. Killing the zombies is uncomfortable and immediately clarifying.
Slippage: The Tell That Your Forecast Is Fiction
Slippage — how often a deal pushes its expected close date — is the single most revealing signal of forecast quality. A deal that has slipped its close date three quarters running is not a Q4 deal; it is a deal that was never qualified and never will close, dressed up as imminent. Chronic slippage across the pipeline means your qualification is weak: deals are being advanced and forecast on hope rather than on the buyer's actual commitment and timeline. The diagnostic measures the slip rate and identifies the serial slippers, and the pattern almost always points back to a missing qualification discipline earlier in the funnel — deals entered the later stages without the evidence that should have been required to put them there.
The most dangerous pipeline is the one that looks healthy on total value but fails every vital sign underneath: thin real coverage, slow velocity, heavy aging, weak conversion, chronic slippage. Founders relax because the headline number is big, right up until the quarter closes at a fraction of forecast. The total is the symptom that hides the disease. Never trust the number without reading the signs beneath it.
A Worked Pipeline Read
Put the five signs together on a real-feeling example. A company needs to close $500K this quarter and reports $2.4M in pipeline — a comforting 4.8× on the headline. The diagnostic begins. Coverage: scrubbing for genuinely qualified deals drops the real pipeline to $1.1M, a true 2.2× against a 25% win rate — already below the safe line, and the quarter is suddenly at risk despite the reassuring headline. Aging: a third of the open value has sat in its current stage longer than 1.5× the cycle, so a meaningful chunk of even that $1.1M is zombie deals that should be marked dead. Slippage: the three largest "imminent" deals have each pushed their close date at least twice, meaning the deals the forecast leans on hardest are the ones least likely to land.
Read individually, none of these alarms might have fired — the headline looked great. Read together, they tell a coherent and urgent story: this pipeline is a fraction as healthy as its total implies, it is padded with stale and slipping deals, and the company is heading for a significant miss it does not yet see coming. That is the entire value of a diagnostic. It converts a number everyone quoted with false confidence into an honest picture early enough to do something about it — pull forward real deals, scrub the zombies, and tighten qualification before the quarter is lost rather than after.
Reading the Signals Together
Any single vital sign can mislead; read together, they diagnose. Strong coverage with slow velocity and heavy aging means your pipeline is padded with stale deals — the total is fake and the real coverage is dangerous. Healthy velocity but thin coverage means the engine works but is starved of qualified opportunities — a genuine top-of-funnel problem, the rare case where more lead generation actually helps. Good coverage and velocity but chronic slippage means qualification is letting unready deals into late stages, so the forecast cannot be trusted even though the volume is there. The art of the diagnostic is in the combinations: the signs constrain each other, and the pattern across all five points to the one underlying problem far more reliably than any metric alone.
Cadence and What Distorts the Read
A pipeline diagnostic is most powerful as a rhythm, not a one-time event. Read the five vital signs lightly every week in your pipeline review — coverage trend, the new zombies, the fresh slippage — so problems surface while they are still fixable, and run the full diagnostic each quarter or whenever the forecast feels untrustworthy. The weekly read is cheap and keeps the pipeline honest; the quarterly read catches the structural drift that accumulates quietly. Teams that build this cadence rarely get blindsided by a quarter, because the signs that predict a miss are visible weeks before the miss itself.
Two things distort the read and are worth guarding against. The first is dirty data: if close dates are not maintained and stages are not updated promptly, every vital sign becomes unreliable — aging looks better than it is, slippage hides, and coverage is computed on fiction. A diagnostic on bad data produces confident, precise, wrong conclusions, so data hygiene is the precondition for the whole exercise. The second is optimism bias in the people maintaining the pipeline: reps and founders both tend to keep hope-deals alive and forecast generously, which is exactly why the diagnostic must be run against hard rules — an objective aging threshold, a scrubbed-qualified definition of coverage — rather than against anyone's gut feeling about which deals are "really going to close this time."
From Diagnostic to Action
A pipeline diagnostic, like any audit, is worth only what you do with it, and the discipline is the same: fix the worst signal first, measure, then move on. If aging is the worst read, the immediate action is a brutal scrub — kill the zombies and watch your real coverage and conversion numbers snap into focus. If slippage is worst, the fix lives upstream in qualification: tighten the exit criteria that let unready deals advance. If velocity is the constraint, the diagnostic told you which of the four levers is cheapest to move. Change one thing, hold the rest constant, and re-measure over a full cycle. The pipeline total will stop being a number you quote nervously and start being a number you can actually forecast against.
There is a second-order payoff that founders underestimate: a diagnosed, scrubbed pipeline changes how you sell, not just how you forecast. When reps know the pipeline is read against hard rules — that zombie deals get killed and unqualified deals do not get to hide in late stages — they stop padding and start qualifying harder up front, because there is no longer any reward for carrying dead weight. The diagnostic, run as a discipline, quietly raises the standard of every deal that enters the pipeline, because the team is now managed on the truth rather than the total. Over a few quarters that shift compounds into a structurally healthier engine: tighter qualification, cleaner data, and a forecast that earns trust because it has stopped being a wish list. The vital signs are not just a measurement; used consistently, they become the management system that keeps the pipeline honest.
A big pipeline number isn't health. It's the symptom most likely to hide the disease.RRClosers
A sales pipeline diagnostic reads past the headline total to five vital signs — coverage, velocity, aging, stage conversion, and slippage. Read together, they tell you whether you have a healthy engine or a graveyard with a big number at the bottom.
Compute real coverage against qualified pipeline, kill the zombies, watch the slippage, and treat velocity as the lever that actually predicts revenue. Then fix the worst signal first, measure, and repeat — until the total is a number you can forecast against, not one you quote and hope.
FAQ: Sales Pipeline Diagnostic
The practice of reading past your headline pipeline total to its vital signs — coverage, velocity, aging, stage conversion, and slippage — to tell whether the pipeline is genuinely healthy or inflated with stale, unqualified deals.
Usually 3–4× the quota you need to close, for a normal win rate. But it must be computed against scrubbed, qualified pipeline — coverage built on the raw total routinely looks safe while the real ratio is dangerously thin.
It combines opportunity count, win rate, deal size, and cycle length into one measure of how much value the engine produces over time. It predicts revenue far better than a static total and shows which of the four levers is cheapest to improve.
Sort open deals by time in current stage and flag anything older than ~1.5× your average sales cycle. These are almost always dead deals inflating your total, corrupting your conversion math, and wasting rep attention.
That qualification is weak and your forecast is fiction. A deal that has pushed its close date several times was never qualified for the stage it's in — the fix lives upstream in tighter exit criteria, not in chasing the slipping deal.
The worst single signal. If aging is worst, scrub the zombies; if slippage is worst, tighten qualification; if velocity is the constraint, pull the cheapest of its four levers. Change one thing, measure over a full cycle, then move on.